Heron Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
140.89 |
158.54 |
178.47 |
210.90 |
249.00 |
283.17 |
| Przychód Δ r/r |
0.00% |
12.53% |
12.57% |
18.17% |
18.07% |
13.72% |
| Przychód (min) |
140.44 |
152.42 |
173.30 |
205.10 |
242.15 |
275.38 |
| Przychód (max) |
141.34 |
164.65 |
183.70 |
216.36 |
255.45 |
290.50 |
| EBITDA (średnia) |
-100.74 |
-113.36 |
-127.61 |
-150.80 |
-178.05 |
-202.48 |
| EBIT (średnia) |
-101.65 |
-114.39 |
-128.77 |
-152.17 |
-179.66 |
-204.31 |
| EBIT % |
-72.15% |
-72.15% |
-72.15% |
-72.15% |
-72.15% |
-72.15% |
| Zysk netto (średni) |
-19.63 |
-2.35 |
10.16 |
31.25 |
53.36 |
58.69 |
| Zysk netto % |
-13.93% |
-1.48% |
5.69% |
14.82% |
21.43% |
20.73% |
| EPS (średnia) |
-0.13 |
-0.02 |
0.07 |
0.21 |
0.35 |
0.39 |
| Liczba analityków (Przychody) |
2 |
3 |
3 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
3 |
1 |
1 |
| symbol |
HRTX |
HRTX |
HRTX |
HRTX |
HRTX |
HRTX |